Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriatic Subjects”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Large-scale testing (Phase 3)UnknownNCT04610476
What this trial is testing

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic ArthritisWithdrawalReduction
University of Erlangen-Nürnberg Medical School 270
Testing effectiveness (Phase 2)Ended earlyNCT03320876
What this trial is testing

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 122
Large-scale testing (Phase 3)Study completedNCT01782937
What this trial is testing

An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis

Who this might be right for
Psoriasis
Kyowa Kirin Co., Ltd. 30
Large-scale testing (Phase 3)Ended earlyNCT05623345
What this trial is testing

Psoriatic Arthritis Study of Izokibep

Who this might be right for
Psoriatic Arthritis
ACELYRIN Inc. 351
Early research (Phase 1)WithdrawnNCT02671188
What this trial is testing

Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis

Who this might be right for
Autoimmune Diseases
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT02404350
What this trial is testing

Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 997
Large-scale testing (Phase 3)Study completedNCT01077362
What this trial is testing

The Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 312
Large-scale testing (Phase 3)Study completedNCT01421069
What this trial is testing

Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis

Who this might be right for
Juvenile Idiopahtic Arthritis
Pfizer 109
Large-scale testing (Phase 3)Study completedNCT02052609
What this trial is testing

Clinical Study of KHK 4827

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 155
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Large-scale testing (Phase 3)Study completedNCT01087788
What this trial is testing

Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
UCB BIOSCIENCES GmbH 409
Testing effectiveness (Phase 2)Study completedNCT01490450
What this trial is testing

Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy

Who this might be right for
Arthritis, Psoriatic
CSL Behring 165
Testing effectiveness (Phase 2)Study completedNCT00126724
What this trial is testing

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Who this might be right for
Arthritis, RheumatoidArthritis, PsoriaticAnkylosing Spondylitis
Targeted Genetics Corporation 120
Testing effectiveness (Phase 2)Ended earlyNCT01516957
What this trial is testing

AMG 827 in Subjects With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Bausch Health Americas, Inc. 168
Testing effectiveness (Phase 2)Study completedNCT03101670
What this trial is testing

Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 131
Large-scale testing (Phase 3)Study completedNCT02376790
What this trial is testing

Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 851
Testing effectiveness (Phase 2)Ended earlyNCT00782613
What this trial is testing

Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Synvista Therapeutics, Inc 30
Large-scale testing (Phase 3)Study completedNCT01925768
What this trial is testing

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 219
Testing effectiveness (Phase 2)Study completedNCT02980692
What this trial is testing

Efficacy and Safety Study of SUNPG1623

Who this might be right for
Active Psoriatic Arthritis
Sun Pharmaceutical Industries Limited 391
Large-scale testing (Phase 3)Study completedNCT03410992
What this trial is testing

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 435
Next Page